“These are obviously very exciting results,” said Dr. Anthony
Fauci, the nation’s top infectious disease doctor. “It’s just as
good as it gets — 94.5% is truly outstanding.”
Moderna heard its results on a call Sunday afternoon with members
of the Data Safety and Monitoring Board, an independent panel
analyzing Moderna’s clinical trial data. Vaccinations could begin
in the second half of December, Fauci said. Vaccinations are
expected to begin with high-risk groups and to be available for
the rest of the population next spring.
In Moderna’s trial, 15,000 study participants were given a
placebo, which is a shot of saline that has no effect. Over
several months, 90 of them developed Covid-19, with 11 developing
severe forms of the disease. Another 15,000 participants were
given the vaccine, and only five of them developed Covid-19. None
of the five became severely ill. The company says its vaccine did
not have any serious side effects. A small percentage of those who
received it experienced symptoms such as body aches and headaches.
I can get used to hearing good news continue rolling in.